Palliative management of fatigue at the close of life - "It feels like my body is just worn out"

被引:47
作者
Yennurajalingam, Sriram [1 ]
Bruera, Eduardo [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Palliat Care & Rehabil Med, Unit 008, Houston, TX 77030 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2007年 / 297卷 / 03期
关键词
QUALITY-OF-LIFE; CANCER-RELATED FATIGUE; PATIENT-CONTROLLED METHYLPHENIDATE; DOUBLE-BLIND; MULTIPLE-SCLEROSIS; COGNITIVE IMPAIRMENT; PHYSICAL-ACTIVITY; HEMOGLOBIN LEVEL; CONTROLLED-TRIAL; UNITED-STATES;
D O I
10.1001/jama.297.3.295
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fatigue is the most common chronic symptom associated with cancer and other chronic progressive diseases. The assessment and treatment of fatigue at or near the end of life can be complex. Some of the challenges include its subjective nature, with great variability in its source, how it is expressed, and how it is perceived, requiring treatment to be based on patient report of frequency and severity; its multidimensional character; and the limited understanding of its pathophysiology. Using the case of an 82-year-old retired nurse with fatigue that could be explained by a number of concurrent conditions, including anemia, weight loss, depression and isolation, dyspnea, deconditioning, and medications, the authors illustrate the clinical approach to assess and treat fatigue at the end of life.
引用
收藏
页码:295 / 304
页数:10
相关论文
共 119 条
  • [1] Elevated levels of circulating interleukin-6 and transforming growth factor-β1 in patients with metastatic prostatic carcinoma
    Adler, HL
    McCurdy, MA
    Kattan, MW
    Timme, TL
    Scardino, PT
    Thompson, TC
    [J]. JOURNAL OF UROLOGY, 1999, 161 (01) : 182 - 187
  • [2] Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer
    Agteresch, HJ
    Dagnelie, PC
    van der Gaast, A
    Stijnen, T
    Wilson, JH
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (04) : 321 - 328
  • [3] ARMITAGE JO, 1998, CLIN ONCOL UPDATES, V1, P1
  • [4] DRONABINOL AS A TREATMENT FOR ANOREXIA ASSOCIATED WITH WEIGHT-LOSS IN PATIENTS WITH AIDS
    BEAL, JE
    OLSON, R
    LAUBENSTEIN, L
    MORALES, JO
    BELLMAN, P
    YANGCO, B
    LEFKOWITZ, L
    PLASSE, TF
    SHEPARD, KV
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (02) : 89 - 97
  • [5] Correlates of physical activity in chronic obstructive pulmonary disease
    Belza, B
    Steele, BG
    Hunziker, J
    Lakshminaryan, S
    Holt, L
    Buchner, DM
    [J]. NURSING RESEARCH, 2001, 50 (04) : 195 - 202
  • [6] Growth hormone, alone and in combination with insulin, increases whole body and skeletal muscle protein kinetics in cancer patients after surgery
    Berman, RS
    Harrison, LE
    Pearlstone, DB
    Burt, M
    Brennan, MF
    [J]. ANNALS OF SURGERY, 1999, 229 (01) : 1 - 10
  • [7] Psychological issues in end-of-life care
    Block, Susan D.
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2006, 9 (03) : 751 - 772
  • [8] The Memorial Delirium Assessment Scale
    Breitbart, W
    Rosenfeld, B
    Roth, A
    Smith, MJ
    Cohen, K
    Passik, S
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 13 (03) : 128 - 137
  • [9] Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: A preliminary report
    Bruera, E
    Driver, L
    Barnes, EA
    Willey, J
    Shen, L
    Palmer, JL
    Escalante, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 4439 - 4443
  • [10] Patient-controlled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial
    Bruera, E
    Valero, V
    Driver, L
    Shen, LR
    Willey, J
    Zhang, T
    Palmer, JL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) : 2073 - 2078